SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001559053-16-000084
Filing Date
2016-11-02
Accepted
2016-11-01 17:36:06
Documents
57
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q prta2016q310-q.htm 10-Q 940168
2 EXHIBIT 31.1 prta2016q310-qxex311.htm EX-31.1 14396
3 EXHIBIT 31.2 prta2016q310-qxex312.htm EX-31.2 14462
4 EXHIBIT 32.1 prta2016q310-qxex321.htm EX-32.1 14640
  Complete submission text file 0001559053-16-000084.txt   4212175

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT prta-20160930.xml EX-101.INS 641458
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20160930.xsd EX-101.SCH 45611
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prta-20160930_cal.xml EX-101.CAL 70264
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prta-20160930_def.xml EX-101.DEF 154653
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20160930_lab.xml EX-101.LAB 519410
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20160930_pre.xml EX-101.PRE 278165
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 650-615-2119
Prothena Corp plc (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35676 | Film No.: 161965744
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences